Ophthalmology · Chattanooga, TN
NPI
1578555835
Since 2005
Specialty
Ophthalmology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1801 Gunbarrel Rd
Chattanooga, TN, 37421
Phone (423) 855-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$249K
3,101 services
Medicare patients, 2024
638
Average age 77
Drug cost, 2024
$1.2M
6,258 prescriptions
Company payments, 2025
$1,770
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle L Robison was code 99214 (office e&m - established), 782 times for 391 patients. In total Michelle L Robison billed 3,101 services in 35 codes, and Medicare paid $249K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 782 | 391 | $80.79 | $63K |
| 92083 Vision, Hearing, and Speech Services | Office | 509 | 400 | $41.11 | $21K |
| 92014 Ophthalmological E&M | Office | 491 | 473 | $78.09 | $38K |
| 92133 Computerized Ophthalmic Imaging | Office | 412 | 410 | $23.60 | $9,723 |
| J7351 Injection, bimatoprost, intracameral implant, 1 microgram | Office | 190 | 12 | $163.50 | $31K |
| 92012 Ophthalmological E&M | Office | 154 | 112 | $55.67 | $8,573 |
| 92020 Ophthalmological E&M | Office | 98 | 91 | $18.02 | $1,766 |
| 76519 Ultrasound - Nonspecific | Office | 65 | 47 | $33.15 | $2,155 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 49 | 32 | $159.45 | $7,813 |
| 92004 Ophthalmological E&M | Office | 38 | 38 | $97.16 | $3,692 |
| 66984 Cataract Surgery | Facility | 36 | 26 | $374.60 | $13K |
| 76514 Ultrasound - Nonspecific | Office | 35 | 35 | $6.86 | $240 |
| 66821 Cataract Surgery | Office | 32 | 24 | $232.82 | $7,450 |
| 92134 Computerized Ophthalmic Imaging | Office | 29 | 29 | $27.22 | $789 |
| 99212 Office E&M - Established | Office | 28 | 27 | $35.19 | $985 |
By year: 2022 $237K for 3,178 services; 2023 $221K for 3,087 services; 2024 $249K for 3,101 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michelle L Robison prescribed most often to Medicare patients was Latanoprost, with 953 prescriptions and refills. In total Michelle L Robison wrote 6,258 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 953 | 2,238 | 297 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 873 | 1,908 | 211 | $20K |
| Lumigan Bimatoprost | 501 | 952 | 133 | $263K |
| Brimonidine Tartrate Generic | 498 | 1,103 | 150 | $26K |
| Dorzolamide Hcl Generic | 482 | 1,037 | 128 | $12K |
| Prednisolone Acetate Generic | 372 | 549 | 207 | $16K |
| Alphagan P Brimonidine Tartrate | 280 | 494 | 77 | $120K |
| Rhopressa Netarsudil Mesylate | 219 | 350 | 48 | $108K |
| Timolol Maleate Generic | 217 | 550 | 78 | $4,281 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 200 | 315 | 47 | $112K |
| Vyzulta Latanoprostene Bunod | 194 | 325 | 48 | $92K |
| Travoprost Generic | 189 | 359 | 47 | $38K |
| Restasis Cyclosporine | 162 | 320 | 67 | $187K |
| Bimatoprost Generic | 157 | 314 | 49 | $21K |
| Combigan Brimonidine Tartrate/Timolol | 142 | 221 | 28 | $50K |
Brand drugs: 2,672 claims; generic drugs: 3,586 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle L Robison $1,770 ($1,770 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $689.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $689 |
| Alcon Vision LLC ALC | 11 | $354 |
| Tarsus Pharmaceuticals, Inc. TARS | 11 | $225 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $211 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $87.86 |
| Thea Pharma Inc. | 3 | $71.62 |
| Dompe US, Inc. | 2 | $55.5 |
| Glaukos Corporation GKOS | 2 | $34.5 |
| Oyster Point Pharma, Inc. | 1 | $23.32 |
| Biotissue Holdings Inc. | 1 | $17.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.